Literature DB >> 3032760

Establishment and characterization of a human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude mice.

T Murakami, H Yano, M Maruiwa, S Sugihara, M Kojiro.   

Abstract

A human cell line (KMCH-1) derived from a surgical specimen of combined hepatocellular and cholangiocarcinoma has been established. The original tumor consisted of both hepatocellular carcinoma of the trabecular type and cholangiocellular carcinoma. This cell line has been maintained for 26 months through 75 passages. KMCH-1 cells show characteristics of adenocarcinoma on light and electron microscopy. They proliferate in culture in a pave stone arrangement. The doubling time of these cells at the 24th passage was 39 hr. Chromosome analysis revealed a chromosome number ranging from 60 to 98, with a modal number of 74. KMCH-1 cells produced tumors several months after subcutaneous and intraperitoneal transplantations into athymic nude mice. Histologically, the subcutaneous tumors were poorly differentiated adrenocarcinoma, while intraperitoneal tumors were moderately to well-differentiated adenocarcinoma. Hepatocellular carcinoma components were not observed. Thus, KMCH-1 cells demonstrate the feature of cholangiocellular carcinoma in vitro and in vivo. This KMCH-1 cell line is the first established combined hepatocellular and cholangiocarcinoma cell line and may contribute to further investigation of combined hepatocellular and cholangiocarcinoma.

Entities:  

Mesh:

Year:  1987        PMID: 3032760     DOI: 10.1002/hep.1840070322

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  25 in total

1.  Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma.

Authors:  Ayano Kabashima; Petra Hirsova; Steven F Bronk; Matthew C Hernandez; Mark J Truty; Sumera Rizvi; Scott H Kaufmann; Gregory J Gores
Journal:  J Hepatol       Date:  2018-03-09       Impact factor: 25.083

2.  MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma.

Authors:  Adrian P Mansini; Maria J Lorenzo Pisarello; Kristen M Thelen; Maetzin Cruz-Reyes; Estanislao Peixoto; Sujeong Jin; Brynn N Howard; Christy E Trussoni; Gabriella B Gajdos; Nicholas F LaRusso; Maria J Perugorria; Jesus M Banales; Sergio A Gradilone
Journal:  Hepatology       Date:  2018-05-21       Impact factor: 17.425

3.  Characterization of a new rat cell line established from 2'AAF-induced combined hepatocellular cholangiocellular carcinoma.

Authors:  R Gil-Benso; A Martinez-Lorente; A Pellin-Perez; S Navarro-Fos; M A Gregori-Romero; C Carda; R Callaghan; A Peydro-Olaya; A Llombart-Bosch
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-01       Impact factor: 2.416

4.  The biliary epithelium presents antigens to and activates natural killer T cells.

Authors:  Elisabeth Schrumpf; Corey Tan; Tom H Karlsen; Jon Sponheim; Niklas K Björkström; Olav Sundnes; Kristian Alfsnes; Arthur Kaser; Douglas M Jefferson; Yoshiyuki Ueno; Tor J Eide; Guttorm Haraldsen; Sebastian Zeissig; Mark A Exley; Richard S Blumberg; Espen Melum
Journal:  Hepatology       Date:  2015-05-20       Impact factor: 17.425

5.  Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.

Authors:  Toru Kawamoto; Kazunori Ishige; Melanie Thomas; Yoriko Yamashita-Kashima; Sei Shu; Nobuyuki Ishikura; Shunichi Ariizumi; Masakazu Yamamoto; Kunihiko Kurosaki; Junichi Shoda
Journal:  J Gastroenterol       Date:  2014-08-12       Impact factor: 7.527

6.  miR-106b-responsive gene landscape identifies regulation of Kruppel-like factor family.

Authors:  Cody J Wehrkamp; Sathish Kumar Natarajan; Ashley M Mohr; Mary Anne Phillippi; Justin L Mott
Journal:  RNA Biol       Date:  2018-02-01       Impact factor: 4.652

7.  Deregulated methionine adenosyltransferase α1, c-Myc, and Maf proteins together promote cholangiocarcinoma growth in mice and humans(‡).

Authors:  Heping Yang; Ting Liu; Jiaohong Wang; Tony W H Li; Wei Fan; Hui Peng; Anuradha Krishnan; Gregory J Gores; Jose M Mato; Shelly C Lu
Journal:  Hepatology       Date:  2016-04-28       Impact factor: 17.425

Review 8.  Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential.

Authors:  Z Y Tang; F X Sun; J Tian; S L Ye; Y K Liu; K D Liu; Q Xue; J Chen; J L Xia; L X Qin; S L Sun; L Wang; J Zhou; Y Li; Z C Ma; X D Zhou; Z Q Wu; Z Y Lin; B H Yang
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

9.  HDAC6 inhibition restores ciliary expression and decreases tumor growth.

Authors:  Sergio A Gradilone; Brynn N Radtke; Pamela S Bogert; Bing Q Huang; Gabriella B Gajdos; Nicholas F LaRusso
Journal:  Cancer Res       Date:  2013-01-31       Impact factor: 12.701

10.  Establishment and characterization of human hepatocellular carcinoma cell line FHCC-98.

Authors:  Chao-Yang Lou; Ying-Ming Feng; Ai-Rong Qian; Yu Li; Hao Tang; Peng Shang; Zhi-Nan Chen
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.